Bioanalytical Testing Services Market - Global Forecast to 2023
Get in-depth analysis of how COVID-19 is impacting the Bioanalytical Testing Services Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Bioanalytical Testing Services Market
Request NowThe global bioanalytical testing services market is projected to reach USD 2,000-2,400 Million by 2023 from USD 1,200-1,400 Million in 2017 at a CAGR of 11-14% during the forecast period. Market growth can be attributed to the growing demand for analytical services for biologics and large-molecule drugs, growing biopharmaceutical pipeline, increasing biopharma approvals, increasing number of clinical trials for biosimilar, increasing number of R&D. On the other hand, pricing pressure faced by major players and shortage of skilled professionals are expected to restrain the overall market growth to a certain extent during the forecast period.
Years considered for this report
- 2017 – Base Year
- 2018 – Estimated Year
- 2023 – Projected Year
Objectives of the Study
- To define, describe, and forecast the bioanalytical testing services market on the basis of type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their market shares and core competencies2 in the global bioanalytical testing services market
- To track and analyze competitive developments such as partnerships, agreements, & collaborations; mergers & acquisitions; product developments; and geographical expansions in the global bioanalytical testing services market
Research Methodology
Top-down and bottom-up approaches are used to validate the size of the global bioanalytical testing services market and estimate the size of various other dependent submarkets. Major players in the market are identified through secondary sources secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, journals and their market revenues are determined through primary and secondary research. Secondary research includes the study of the annual and financial reports of top market players, whereas primary research includes extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets are determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study are accounted for, viewed in extensive detail, being verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and are presented in this report.
The global bioanalytical testing services market includes some of the major players such as Charles River Laboratories International Inc. (U.S.), BioReliance Corporation (U.S.), WuXi PharmaTech (Cayman) Inc. (China), Bioclin Research Laboratories (Ireland), Eurofins Scientific SE (Luxembourg), SGS (Switzerland), LabCorp (U.S.), PPD Inc. (U.S.), Intertek Group Plc. (U.K.) and PRA Health Sciences (U.S.)
Target Audience:
- Healthcare Institutions (Hospitals, Medical Schools, and outpatient Clinics)
- Biopharmaceutical companies
- Contract development and manufacturing organization (CDMO)
- Clinical Research organizations/ contract research organizations
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Scope of the Report
The research report categorizes the global bioanalytical testing services market into the following segments and subsegments:
Global Bioanalytical Testing Services Market, By Type
- Introduction
- Cell based assays
- Bacterial
- Viral
- Virology testing
- In-vitro assays
- In-vivo assays
- Species-specific viral PCR assays
- Serology, immunogenicity & neutralizing antibodies
- Bacterial
- Viral
- Toxicology services
- In-vitro toxicology
- In-vivo toxicology
- Others
- Biomarker testing
- Metabolic profiling and mass balance studies
- Method development optimization and validation
- Pharmacokinetic testing
- Other services
- Biologics characterization
- Extractable & leachable testing
- Stability testing
Global Bioanalytical testing services Market, By Application
- Introduction
- Oncology
- Immunology
- Neurology
- Hematology
- Others
Global Bioanalytical testing services Market, by End User
- Introduction
- Biopharmaceutical companies
- Contract development and manufacturing organization (CDMO)
- Clinical research organizations/contract research organizations
Global Bioanalytical testing services Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Latin America
- Middle East and Africa
Available customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Asia-Pacific bioanalytical testing services market into South Korea, Australia, New Zealand, and others
- Further breakdown of the Rest of Europe bioanalytical testing services market into Belgium, Russia, the Netherlands, Switzerland, and others
- Further breakdown of the Rest of Latin America bioanalytical testing services market into Argentina, Colombia, Chile, and others
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Sources
2.1.2 Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraints
5.2.3 Opportunities
5.2.4 Challenges
6 Global Bioanalytical Testing Services Market, By Type
6.1 Introduction
6.2 Cell Based Assays
6.2.1 Bacterial
6.2.2 Viral
6.3 Virology Testing
6.3.1 In-Vitro Assays
6.3.2 In-Vivo Assays
6.3.3 Species-Specific Viral Pcr Assays
6.4 Serology, Immunogenicity & Neutralizing Antibodies
6.4.1 Bacterial
6.4.2 Viral
6.5 Toxicology Services
6.5.1 In-Vitro Toxicology
6.5.2 In-Vivo Toxicology
6.5.3 Others
6.6 Biomarker Testing
6.7 Metabolic Profiling and Mass Balance Studies
6.8 Method Development Optimization and Validation
6.9 Pharmacokinetic Testing
6.10 Other Services
6.10.1 Biologics Characterization
6.10.2 Extractable & Leachable Testing
6.10.3 Stability Testing
7 Global Bioanalytical Testing Services Market, By Application
7.1 Introduction
7.2 Oncology
7.3 Immunology
7.4 Neurology
7.5 Hematology
7.6 Others
8 Global Bioanalytical Testing Services Market, By End User
8.1 Introduction
8.2 Biopharmaceutical Companies
8.3 Contract Development and Manufacturing Organization (CDMO)
8.4 Clinical Research Organizations/Contract Research Organizations
9 Global Bioanalytical Testing Services Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Latin America
9.6 Middle East and Africa
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situations & Trends
10.3.1 New Product Launches
10.3.2 Agreements, Partnerships, & Collaborations
10.3.3 Mergers and Acquisitions
10.3.4 Expansions
11 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Charles River Laboratories International Inc.
11.2 Bioreliance Corporation
11.3 Wuxi Pharmatech
11.4 Bioclin Research Laboratories
11.5 Eurofins Scientific Se
11.6 SGS
11.7 Labcorp
11.8 PPD Inc.
11.9 Intertek Group PLC.
11.10 PRA Health Sciences
11.11 Inventiv Health Inc.
11.12 Icon PLC.
11.13 Celerion
11.14 Parexel International
11.15 Envigo
11.16 Frontage
11.17 Bioagilytix Labs, LLC
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Bioanalytical Testing Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Bioanalytical Testing Services Market